Joint Formulary & PAD

Solifenacin - Overactive bladder (adults)

You are here : Home > Formulary Search > Solifenacin - Overactive bladder (adults)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :
Important
Preferred
1st line unless contra-indicated
 

Status 2

Green (see narrative)
Formulations :
  • Oral suspension
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
R
SPC
Restrictions / Comments :
Important
Only for patients with swallowing difficulties. Prescribe as solifenacin 1mg/ml oral SUSPENSION
 

Status 3

Non Formulary
Formulations :
  • Oral solution
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
NFD1
SPC
Restrictions / Comments :
Important
Prescribe as solifenacin 1mg/ml oral SUSPENSION

Documentation

Guidelines (Local)
Selection tool for OAB treatments - Nov 2024
Patient resource
Leaflet-for-trial-of-stopping-OAB-drugs - anticholinergics - Mar 24
Webpage
NICE Clinical guideline [CG97] : Lower urinary tract symptoms in men: management
Webpage
LUTS in Men - Management of Overactive Bladder - CKS guidance
Webpage
Urinary incontinence in women - CKS guidelines

PAD Profile

ChemicalSubstance :
Solifenacin
Indication :
Overactive bladder (adults)
Group Name :
Keywords :
antimuscarinics, OAB, urge incontinence, urinary incontinence, urinary frequency, LUTS, urinary urgency, anticholinergics, urinary urgency
Brand Names Include :
Vesicare
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Overactive bladder (adults)
Supporting Documents :
5
Traffic Light Entries :
3

Committee Recommendations (2)

06 Mar 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The APC supports patients in trialling a treatment break of their overactive bladder medicines.

A "Leaflet for trial of stopping anticholinergics" can be found in the documents section below.

05 Jul 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Solifenacin is the 1st line treatment option.

Patients with swallowing difficulties

Solifenacin 1mg/ml oral SUSPENSION sugar free is the preferred option in patients with swallowing difficulties.

Solifenacin 5mg/5ml oral solution is non-formulary due to it being significantly more expensive than the suspension in primary care.

See Selection Tool for locally agreed OAB treatment options

Other Indications

Below are listed other indications that Solifenacin is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Overactive bladder (adults).